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Abstract  12 
An LC-MS/MS “dilute and shoot” method for the determination of 295 fungal and bacterial 13 
metabolites was optimized and validated according to the guidelines established in the 14 
Directorate General for Health and Consumer Affairs of the European Commission (SANCO) 15 
document No. 12495/2011. Four different types of food matrices were chosen for validation: 16 
apple puree for infants (high water content), hazelnuts (high fat content), maize (high starch and 17 
low fat content) and green pepper (difficult or unique matrix). Method accuracy and precision 18 
was evaluated using spiked samples in five replicates at two concentration levels. Method 19 
trueness was demonstrated through participation in various proficiency tests. Although the 20 
method covers a total number of 331 analytes, validation data were acquired only for 295 21 
analytes, either due to the non-availability of analytical standards or due other reasons described 22 
in this paper. Concerning the apparent recovery, the percentage of 295 analytes matching the 23 
acceptable recovery range of 70-120% lied down by SANCO varied from 21% in green pepper 24 
to 74% in apple puree at the highest spiking level. At the levels close to limit of quantification 25 
only 20-58% of the analytes fulfilled this criterion. The extent of matrix effects was strongly 26 
dependent on the analyte/matrix combination. In general, the lowest matrix effects were 27 
observed in apple puree (59% of analytes were not influenced by enhancement/suppression at all 28 
at the highest validation level). The highest matrix effects were observed in green pepper, where 29 
only 10% of analytes did not suffer from signal suppression/enhancement. The repeatability of 30 
the method was acceptable (RSD ≤ 20) for 97% of all analytes in apple puree and hazelnuts, for 31 
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95% in maize and for 89% in green pepper. Concerning the trueness of the method, Z-scores 32 
were generally between -2 and 2, despite a broad variety of different. Based on these results it 33 
can be concluded that quantitative determination of mycotoxins by LC-MS/MS based on a 34 
“dilute and shoot” approach is also feasible in case of complex matrices.  35 
Highlights 36 
 An LC-MS/MS method for 295 bacterial and fungal toxins was developed 37 
 The method was validated for four very different food matrices  38 
 The trueness of the method is proven through proficiency test materials 39 
 The majority of the analytes fulfill the method accuracy criteria  40 
 It is feasible to apply the method also for complex matrices without prior clean-up 41 
Keywords 42 
apple puree, hazelnuts, maize, green pepper, food contaminants, mycotoxins 43 
1. Introduction 44 
Mycotoxins are defined as low-molecular-weight natural products produced as secondary 45 
metabolites by fungi. By definition, they are toxic to vertebrates and other animal groups in low 46 
concentrations, causing acute as well as chronic diseases [1]. Mycotoxins exhibit a great 47 
diversity in their chemical structure, which explains that their toxicities and target organs also 48 
vary [2]. Over the years, health concerns related to mycotoxins have increased [3] and several 49 
regulations have been set into force to control the maximum levels of mycotoxins in food and 50 
feed in many countries. For instance, the European Union has laid down maximum levels for 51 
certain mycotoxin-matrix combinations in Commission Regulation 1881/2006/EC [4]. 52 
Regulations are based on the evaluation of risk assessment (hazard and exposure) but also reflect 53 
agriculturally achievable levels in different foodstuffs. As exposure assessment is an important 54 
aspect of risk assessment, validated analytical methods and the implementation of analytical 55 
quality assurance are necessary to provide a reliable assessment on the toxin intake [5]. The 56 
complexity of food samples together with the low concentrations at which contaminants usually 57 
occur require highly sensitive, selective and reliable analytical techniques [6]. 58 
  
 
3 
During last decade the coupling of liquid chromatography (HPLC or UHPLC) to tandem mass 59 
spectrometry (MS/MS) has enabled the development of highly selective, sensitive and accurate 60 
methods for mycotoxin determination. Several methods have been published for the 61 
identification and accurate quantification of single or chemically related mycotoxins in several 62 
matrices [7]. However, different classes of mycotoxins are often found to co-occur as (i) some 63 
fungal species are capable to produce different classes of mycotoxins and (ii) susceptible 64 
commodities can be affected by several fungi if the environmental conditions (temperature, 65 
water activity) favor their growth. Therefore, different analytical methods are often employed to 66 
cover all mycotoxins addressed by the regulations. The techniques used are based on TLC, 67 
HPLC-UV, HPLC-fluorescence frequently in combination with time consuming purification step 68 
or immunochemical methods such as ELISA [8]. 69 
The development of LC-MS/MS based multi-mycotoxin methods tries to overcome the need for 70 
sophisticated clean-ups and/or multiple analytical techniques, although the chemical diversity of 71 
mycotoxins causes a big obstacle to be overcome [2]. Therefore, extraction of a wide range of 72 
target compounds from a variety of matrices has to be realized. Studies on generic extraction 73 
methods for multiple contaminants in different food and feed matrices have demonstrated that 74 
mixtures of acidified water with organic solvents (methanol, acetonitrile or acetone) are the most 75 
suitable extraction solvents [9, 10].  76 
Every clean-up step and even a rather unspecific QuEChERS-like approach [11] limit the 77 
number of analytes as some of the target substances might not be amenable to the chosen 78 
procedure [12]. On the other hand, reducing the sample clean-up to a minimum (i.e. injection of 79 
raw extracts) will result in suppression or enhancement of the analyte response during the 80 
ionization process. The influence of these matrix effects is the major challenge in developing 81 
reliable quantitative multi-analyte methods [13]. Therefore, considerable efforts to control matrix 82 
effects should be carried out to obtain accurate results. The use of stable isotope dilution assays 83 
(SIDA) seems to be the best alternative to correct matrix effects. Several methods have been 84 
validated using isotopically labelled internal standards [14-16]. However, the limited availability 85 
of labelled internal standards for non-regulated toxins and the comparably high costs of 86 
isotopically labelled standards are the main drawbacks. Another common approach to deal with 87 
matrix effects is the compensation of the signal suppression/enhancement through the usage of 88 
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matrix matched standards (i.e. blank sample extracts fortified with an appropriate amount of a 89 
multi-analyte standard). Here the availability of analyte-free samples (which is especially 90 
difficult for certain analyte/matrix combinations such as deoxynivalenol in maize) and repeatable 91 
extraction efficiencies as well as matrix effects for all individual samples of a given commodity 92 
are the major challenges [17-22].  93 
To assure reliable quantification at a high level of trueness, in-house validation has to be 94 
performed, preferably according to international guidelines. The SANCO document for the 95 
development of multi-analyte methods in pesticides residue analysis recommends that at least 96 
one representative commodity from each commodity group shall be validated and evidence for 97 
fitness of purpose shall be provided [22]. This approach has been successfully applied in the field 98 
of pesticide analysis [23-25] but has hardly been employed for methods devoted to mycotoxins, 99 
for which most methods focus on single commodities (mainly grain-based matrices). However, a 100 
few examples can be found for multi-mycotoxin methods which have been validated for a wider 101 
range of matrices [9, 10, 18, 26-28].  102 
The aim of this work was to evaluate the performance of a multi-analyte method for mycotoxins 103 
and other fungal as well as bacterial metabolites. Furthermore, a validation procedure in 104 
accordance to SANCO No. 12495/2011 was developed and applied to four model matrices. The 105 
range of analytes finally covered a total of 295 secondary metabolites for which validation data 106 
are presented in four different matrices. The model matrices were chosen as representative 107 
commodities belonging to the respective commodity groups according SANCO (each 108 
commodity group includes matrices of similar properties). Other aspect of selection was the 109 
relevance of the matrix with respect of mycotoxin contamination, i.e. the commodities which are 110 
commonly contaminated with mycotoxins. Therefore, apple puree for infants (high water 111 
content), hazelnuts (high fat content), maize (high starch or protein content, low fat content) and 112 
green pepper (complex matrix) were chosen. In case of the mycotoxins addressed by regulations, 113 
the precision of the method was verified through the participation in proficiency tests. 114 
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2. Material and methods 115 
2.1 Chemicals and reagents 116 
LC gradient grade methanol and acetonitrile as well as MS grade ammonium acetate and glacial 117 
acetic acid (p.a.) were purchased from Sigma Aldrich (Vienna, Austria). A Purelab Ultra system 118 
(ELGA LabWater, Celle, Germany) was used for further purification of reverse osmosis water. 119 
Standards of fungal and bacterial metabolites were obtained either as gifts from various research 120 
groups or from the following commercial sources: Romer Labs
®
Inc. (Tulln, Austria), Sigma-121 
Aldrich (Vienna, Austria), Iris Biotech GmbH (Marktredwitz, Germany), Axxora Europe 122 
(Lausanne, Switzerland) and LGC Promochem GmbH (Wesel, Germany). Stock solutions of 123 
each analyte were prepared by dissolving the solid substance in acetonitrile (preferably), 124 
acetonitrile/water 1:1 (v/v), methanol, methanol/water 1:1 (v/v) or water. Thirty-four combined 125 
working solutions were prepared by mixing the stock solutions of the corresponding analytes for 126 
easier handling and were stored at −20°C. The final working solution was freshly prepared prior 127 
to spiking experiments by mixing of the combined working solutions. 128 
2.2 Samples 129 
Four samples of different matrix complexity were chosen for the method validation. Apple puree 130 
was taken as a high water containing matrix. Matrices with high fat content were represented by 131 
hazelnuts, and cereals and high starch matrices by maize. Green pepper was used as a model 132 
matrix for the validation of “difficult and unique commodities” [22].  133 
The following proficiency testing samples were used for the verification of the method trueness: 134 
(i) FAPAS
®
 testing materials – peanuts (T01044), maize (T2246, T2262), cereals (T1786) and 135 
cereal breakfast (T2257) provided by The Food and Environment Research Agency (York, 136 
United Kingdom); (ii) Proficiency Testing Scheme samples – peanut cake (04-0231), peanut 137 
paste (02-1331, 04-1331), animal feed (02-3031, 03-3031, 04-3031), wheat (05-0631, 03-2331), 138 
wheat draff (02-2831), pepper (01-1031, 01-3231), raisins (02-3131), maize (04-0731, 05-0731, 139 
03-0731) milk powder (04-0331), coffee (02-1731), baby food (01-3331, 01-3431), pistachio 140 
paste (03-1431), liquorice (01-3531), oat (02-2931) were obtained from Bipea (Gennevilliers, 141 
France); (iii) CODA-CERVA proficiency test (oat flour) from 2013 organized by Belgian 142 
National Reference Laboratory for Mycotoxins in Food and Feed. 143 
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2.3 Sample preparation 144 
Model samples were ground using an Osterizer blender (Sunbeam Oster Household Products, 145 
Fort Lauderdale, Florida, USA). For spiking the model matrices, appropriate amounts of the final 146 
working solution were added to 0.5 g of sample. The samples were placed at darkness to avoid 147 
analyte degradation and stored overnightat room temperature to allow the evaporation of the 148 
solvent and to establish equilibration between analytes and matrix. After this period, 2 mL of 149 
extraction solvent (acetonitrile/water/acetic acid 79:20:1, v/v/v) was added. The samples were 150 
extracted for 90 min using a GFL 3017 rotary shaker (GFL, Burgwedel, Germany) and 151 
subsequently centrifuged for 2 min at 3,000 rpm (radius 15 cm) on a GS-6 centrifuge (Beckman 152 
Coulter Inc., Fullerton, CA). The extracts were transferred into glass vials using Pasteur pipettes, 153 
and 350μL aliquots were diluted with the same volume of dilution solvent 154 
(acetonitrile/water/acetic acid 20:79:1, v/v/v). After appropriate mixing, 5 μL of the diluted 155 
extract was injected into the LC-MS/MS system without further pre-treatment. It should be noted 156 
that the whole procedure was miniaturized only for validation purposes in order to decrease an 157 
amount of standards needed for spiking. In routine analysis, 5 g of sample is extracted with 20 158 
mL of extraction solvent.  159 
2.4 Method validation  160 
2.4.1 Spiking experiments and the preparation of calibration curves 161 
As outlined above, method validation was performed according to SANCO validation criteria 162 
[22]. For the determination of the performance characteristics of the method for all four model 163 
matrices, spiking experiments were carried out at four different concentration levels (each in five 164 
repetitions) resulting in the relative concentrations of 1:3:10:30 in the final diluted extracts. The 165 
concentration ranges of the spiked samples were chosen to cover the respective limits of 166 
detection of each toxin, estimated linear range of calibration, legislation limits of regulated 167 
toxins, as well as the levels commonly found in naturally contaminated samples. External 168 
calibration was prepared by dilution of appropriate amounts of the final working solution with 169 
acetonitrile/water/acetic acid (49.5/49.5/1, v/v/v) at levels corresponding to those in spiked 170 
samples. Taking into account the matrix induced signal enhancement or suppression of target 171 
analytes, two additional calibration points (one above and one below the spiking concentration 172 
range) were prepared to ensure that all spiking levels fall into the calibration range. For the 173 
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assessment of matrix effects and extraction efficiency (recovery), the diluted extracts (blank 174 
extracts) of each model matrix prepared according to the Section 2.3 were fortified at the 175 
concentration range matching the external calibration.  176 
2.4.2 Data evaluation 177 
The peaks were integrated and linear, 1/x weighted, calibration curves were constructed from the 178 
data obtained from the analysis of each sample type (spiked sample, neat solvent standard, 179 
spiked extract) using MultiQuant
TM
2.0.2 software (AB Sciex, Foster City, California, USA) to 180 
evaluate the linearity of the method. Further data evaluation was carried out in Microsoft Excel 181 
2007. All the other performance characteristics of the method (recovery, apparent recovery, 182 
repeatability and matrix effects) were evaluated at each spiking level for all model matrices. First 183 
of all, the average value from the peak areas of five replicates of spiked samples was calculated. 184 
Recovery (RE) of the extraction step and the apparent recovery (RA) were obtained by comparing 185 
the average area of the spiked samples (n=5) to the average area of two replicates of matrix-186 
matched standard and neat solvent standard, respectively, measured at the beginning and at the 187 
end of the set of the respective matrix. Matrix induced enhancement or suppression (SSE) was 188 
assessed by comparison of respective matrix-matched standards with the neat solvent standards. 189 
All the calculations were performed according to the following equations: 190 
Recoveries (extraction efficiency) were calculated according to the Equation 1. 191 
 192 
 
 
(1) 
 193 
Apparent recoveries (absolute recoveries of the method) were calculated as follows: 194 
 195 
 
 
(2) 
 196 
Matrix effects were expressed as SSE 197 
 198 
 
 
(3) 
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 199 
The repeatability of the method was expressed as the relative standard deviation (RSD) 200 
calculated from five replicates of the spiked samples. Concerning the limits of quantification 201 
(LOQ), they were taken as the lowest validated spiking levels (LL) for which the method 202 
performance acceptability criteria were still met, i.e. mean recovery for each representative 203 
commodity in the range of 70-120%, with an RSD≤20% [22]. In addition, the more tedious 204 
“classic” approach based on the signal to noise ratios (S/N) of 10/1 [29] was applied only to 29 205 
most important analytes including all mycotoxins addressed by EU regulations and several other 206 
prevalent fungal metabolites. In this case, the limits of detection (LODs) and the LOQs were 207 
estimated with respect to the signal of the less intensive (LOD) and more sensitivive (LOQ) 208 
selected reaction monitoring (SRM) transition. S/N ratios were assessed at the lowest reliably 209 
visible concentration level of the spiked samples individually for each of the five replicates. 210 
LODs and LOQs were calculated from the average of S/N ratios as follows: 211 
 212 
 
 
(4) 
 213 
 
 
(5) 
 214 
2.5 Instrumental parameters 215 
Detection and quantification was performed with a QTrap 5500 MS/MS system(Applied 216 
Biosystems, Foster City, CA) equipped with a TurboV electrospray ionization (ESI) source and a 217 
1290 series UHPLC system (Agilent Technologies, Waldbronn, Germany). Chromatographic 218 
separation was performed at 25°C on a Gemini
®
 C18-column, 150×4.6 mm i.d., 5 μm particle 219 
size, equipped with a C18 security guard cartridge, 4×3 mm i.d. (all from Phenomenex, Torrance, 220 
CA, US). Elution was carried out in binary gradient mode. Both mobile phases contained 5 mM 221 
ammonium acetate and were composed of methanol/water/acetic acid 10:89:1 (v/v/v; eluent A) 222 
and 97:2:1 (v/v/v; eluent B), respectively. After an initial time of 2 min at 100% A, the 223 
proportion of B was increased linearly to 50% within 3 min. Further linear increase of B to 100% 224 
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within 9 min was followed by a hold-time of 4 min at 100% B and 2.5 min column re-225 
equilibration at 100% A. The flow rate was 1000 μL min−1. ESI-MS/MS was performed in the 226 
scheduled selected reaction monitoring (sSRM) mode both in positive and negative polarities in 227 
two separate chromatographic runs. The sSRM detection window of each analyte was set to the 228 
respective retention time ±27 s and ±42 s in positive and in negative mode, respectively. The 229 
target scan time was set to 1 s. The settings of the ESI source were as follows: source 230 
temperature 550°C, curtain gas 30 psi (206.8 kPa of max. 99.5% nitrogen), ion source gas 1 231 
(sheath gas) 80 psi (551.6 kPa of nitrogen), ion source gas 2 (drying gas) 80 psi (551.6 kPa of 232 
nitrogen), ion-spray voltage −4,500 V and +5,500 V, respectively, collision gas (nitrogen) 233 
medium. The optimization of the analyte-dependent MS/MS parameters was performed via 234 
direct infusion of standards (diluted in a 1:1 mixture of eluent A and B) into the MS source using 235 
a syringe injection at a flow rate of 10 μL/min, see Appendix A for the corresponding values. 236 
The acquisition of 2 sSRM transitions per analyte (with the exception of moniliformin and 3-237 
nitropropionic acid, that each exhibit only one fragment ion), allowed to confirm the identity of 238 
the positive results according to validation guidelines [22, 30]. 239 
3. Results and discussion 240 
3.1 Method extension and the optimization of the LC-MS/MS parameters 241 
A multi-analyte LC-MS/MS method based on a “dilute and shoot” approach was originally 242 
designed for the determination of 39 mycotoxins in cereals in 2006 [17]. Since then the method 243 
has continuously been extended to a wide range of additional secondary metabolites of fungi and 244 
bacteria. This multi-analyte approach was applied to study newly isolated fungal species, to 245 
investigate fungal and bacterial metabolites in indoor environments and to study the spectrum of 246 
(toxic) secondary metabolites to which humans and animals are exposed through the food and 247 
feed chain [12, 27, 28]. Although in the meantime UHPLC has become available and has been 248 
successfully used in mycotoxin analysis to achieve lower LODs and shorter analysis time [19, 249 
21, 26] we have refrained from changing from HPLC to UHPLC for two reasons. On the one 250 
hand, UHPLC columns are not compatible to turbid samples (as they tend to clog after a few 251 
injections) whereas we did not face such problems when using standard HPLC column (we 252 
found filtration not to be an option as all tested materials caused losses of certain compounds). In 253 
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addition On the other hand, the use of UHPLC is related to narrower peaks, which demands a 254 
decreased cycle time in LC-MS/MS in order to obtain an appropriate number of data points per 255 
peak. This inevitable emphasizes the problem of achieving sufficient dwell times in multi-256 
analyte methods. 257 
One major limitation of multi-analyte analytical methods in repeatable quantification is the time 258 
that is available for data acquisition of each SRM transition. In the first place we transferred our 259 
previously published method which covered 186 secondary metabolites [28] from a QTrap 4000 260 
to a QTrap 5500 before we extended the method to a greater range of analytes. On the one hand, 261 
the QTrap 5500’s innovations in the mechanical design (larger orifice entrance, RF-quadrupole 262 
QJet, curved collision cell) as well as in the ion path electronics allow higher sensitivity. On the 263 
other hand, also an increase in the number of sSRM transitions per chromatographic run (lower 264 
dwell time among sSRM transitions) without loss of sensitivity can be achieved due to a higher 265 
acquisition speed. 266 
The differences in the mechanical design between the instruments are mainly associated with 267 
changes in the ion source parameter settings (curtain gas, ion spray voltage, source temperature, 268 
ion source gases). The flow rates of all gases were increased to ensure an efficient evaporation of 269 
the mobile phase, and thus avoid passing of liquid through the large orifice entrance. Regarding 270 
analyte-dependent MS/MS parameters (declustering potential, collision energy, cell exit 271 
potential), we followed the manufacturer’s recommendations to increase the declustering 272 
potentials (DP) of [M+H]
+
 and [M-H]
- 
optimized on the QTrap 4000 by 30 V instead of 273 
individual re-optimization of each analyte. Nevertheless, we chose 30 analytes for the individual 274 
re-optimization on the QTrap 5500 to check the difference in analyte-dependent parameters 275 
values between both instruments. The optimized ‘5500’ DP values of [M+H]+ ions were all 20-276 
30 V higher compared to those on the QTrap 4000. For instance, the DP value of [M+H]
+
 of 277 
ochratoxin A was increased from 61 V to 86 V. The differences for NH4
+
 adducts (T-2 toxin :DP 278 
4000 = 76 V and DP 5500 = 101 V) and Na
+ 
adducts were lower than the recommended 30 V 279 
(HT-2:DP 4000 = 46 V and DP 5500 = 56 V). Similarly, the formation of [M+CH3COO]
-
 280 
adducts (deoxynivalenol: DP 4000 = -40 V and DP 5500 = -60 V; 3-acetyldeoxynivalenol: DP 281 
4000 = -45 V and DP 5500 = -55 V)required less than 30 V increase in DP values. However, the 282 
increase of all ‘4000’ DPs by 30 V was sufficient, as the optimal range of ‘5500’ DPs of each 283 
respective analyte is broader compared to the ‘4000’ instrument. The settings of other analyte-284 
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dependent parameters (e.g. collision energy, CE) were the same for both instruments and did not 285 
require any further optimization. 286 
Due to the lower QTrap 5500 acquisition mass range of 1250 Da, the analytes of molecular 287 
weight higher than 1200 Da had to be excluded from the current method or, if possible, re-288 
optimized as double charged precursor [M+2H]
2+
 ions. For example, actinomycin D (MW 289 
1255.42 Da) does not give a stable [M+2H]
2+
 ion, and could thus not be included in the new 290 
method. However, cyclosporine A was successfully re-optimized and transfer from the negative 291 
to the positive mode giving an intensive precursor ion of m/z of 601.9. Apart from 186 analytes 292 
involved in our previous QTrap 4000 method, further 145 analytes were newly included. The list 293 
of all analytes together with the optimized values of ESI-MS/MS parameters is given in 294 
Appendix A. 295 
Finally, the developed method accommodated a total number of 331 analytes including 288 296 
fungal and 43 bacterial secondary metabolites and according to the availability of the analytical 297 
standards was finally validated for a total of 295 analytes.  298 
As the dwell times in the sSRM mode are automatically generated by the software based on the 299 
number of SRM transitions scheduled for a particular point in time and the target cycle time, it is 300 
recommended to limit the number of co-eluting compounds (concurrent sSRM transitions). Due 301 
to the large number of analytes that are scanned in the positive mode the LC gradient had to be 302 
re-optimized to achieve a better distribution of the related sSRM detection windows and thus a 303 
more effective utilization of the acquisition time. A steeper gradient elution within 2
nd
 and 5
th
 304 
min in connection with gradient flattening between 5
th
 and 14
th
 min led to a more favorable 305 
distribution of sSRM transitions with the exception of the period between 7
th
 and 9
th
 min. For 306 
this reason, a few analytes (gibberellic acid, meleagrin, agistatin B and altenuene) eluting in this 307 
period were transferred to the negative ionization mode in which an acceptable sensitivity was  308 
achieved as well.  309 
3.2 Validation of the method 310 
Currently, no directive or guidance for the validation of analytical methods for the determination 311 
of multiple mycotoxins or for multiple analytes in general is established. The only available 312 
guideline, the Commission Decision 2002/657/EC [30], provides some requirements and 313 
recommendations concerning the performance of analytical methods for official control and the 314 
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interpretation of results. However, the guidance provided is insufficient for multi-analyte 315 
methods for a couple of reasons: A definition of matrix effects and their evaluation is missing, 316 
the term recovery is not exactly specified (whether it is extraction efficiency or apparent 317 
recovery), and the determination of LOD and LOQ by spiking of 20 replicates at one level for 318 
each matrix is not feasible for hundreds of analytes due to the costs of analytical standards. 319 
Therefore, we decided to validate the given multi-analyte method according to SANCO protocol 320 
No. 12495/2011 [22]. Although the validation criteria have been laid down for pesticide multi-321 
residue determination only, they represent the only “real-life” guidelines available for methods 322 
involving hundreds of analytes with a wide range of physico-chemical properties. Since the 323 
method is used for the analysis of wide range of matrices, including non-traditional matrices, 324 
such as cassava or liquorice, comprehensive validation of each individual matrix for more than 325 
three hundred of analytes would be very expensive and time-consuming. Hence only one 326 
representative commodity from each matrix category, as suggested by SANCO, was included in 327 
the validation of our multi-analyte method. As mentioned in section 2.2, we chose four model 328 
matrices (apple puree, hazelnuts, maize, green pepper) representing the category groups that are 329 
relevant regarding mycotoxin contamination. 330 
The performance characteristics of the method obtained for all 295 analytes are summarized in 331 
Appendix B. Despite having 331 compounds included in the current method, not all of them 332 
could have been successfully validated for several reasons: (i) analytical standard not available 333 
(e.g. 4-monoacetoxyscirpenol, decalonectrin, PR-toxin, trypacidin), (ii) instability of an analyte 334 
in the final working standard solution (e.g. bacitracin, cephalosporin C, chetoseminudin A, 335 
cytromycetin, penicillin G), (iii) low concentration of analytical standard for spiking (15-336 
hydroxyculmoron, chromomycin, lolitrem B, rapamycin, ustiloxin B). The validation for some 337 
other analytes (e.g. spyramycin, tylosin, josamycin, fumonisin B6, dinactin) has been done only 338 
by spiking with fungal extract as a substitution of analytical standards which were not available 339 
on the market at that time. 340 
3.2.1 Method accuracy 341 
Apparent recovery (RA) and matrix effects (SSE) strongly vary depending on the analyte/matrix 342 
combination. As we use a neat solvent calibration and spiked samples in the routine analysis 343 
rather than matrix-matched standards, showing the method accuracy on the apparent recoveries 344 
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(calculated according Equation 2), expressing both the extraction efficiency and the matrix 345 
effects, is more “real-life” and relevant than showing data on the recovery of extraction step (RE) 346 
(Equation 1). 347 
3.2.1.1 Apparent recovery 348 
The distribution of RA for 295 analytes in apple puree, hazelnuts, maize and green pepper is 349 
depicted in Figure 1. The highest validated level (HL) corresponds to 1:10 dilution of the final 350 
working solution of the analytical standards. For the lowest validated level (LL), the lowest 351 
spiking level reliably detectable at five repetitions (RSD < 20%) through both MRM transitions 352 
was taken into account. Concerning the apparent recovery calculated at the HL, 74%, 68%, 64% 353 
and 21% of analytes in apple puree, hazelnuts, maize and green pepper, respectively, were in the 354 
range of 70-120% as recommended by SANCO [22]. For the analytes out of this range, either 355 
high matrix suppression/enhancement (e.g. aflatoxins, alternariol and emodin in pepper) or low 356 
extraction efficiency, for instance, 3-nitropropionic acid in hazelnuts was observed (the 357 
somewhat lower extraction efficiencies in apple puree are partially due to the water content of 358 
the sample (50 rel. %), which accounts for a increase of 12% of the volume of the raw extract.) 359 
The lower apparent recovery for some analytes (e.g. chanoclavine and HT-2 toxin in pepper) was 360 
caused by a combination of low extraction efficiency and matrix effects which was most 361 
pronounced in green pepper (Figure 2). Therefore, 8% of the analytes (e.g. ergocryptine, α-362 
zearalenol, cerulenin, citrinin) were not detectable in green pepper at all, while for the other 363 
matrices less than 4% of the analytes could not be detected. Concerning the LL, the percentage 364 
of analytes matching the RA of 70-120% was lower than at the HL. The RA for apple puree, 365 
hazelnuts and maize was 56%, 56% and 58%, respectively. In green pepper, the RA of 70-120% 366 
was achieved only for 20% of analytes. Altogether 25% of the compounds were not detected in 367 
green pepper (for all the other validated matrices only <12% of analytes) at any lower level than 368 
the highest validated level.  369 
3.2.1.2 Matrix effects  370 
SSE (Equation 3) was observed for all matrices. The extent of SSE was strongly dependent on 371 
the analyte/matrix combination. As there is no acceptable range concerning the SSE in the 372 
SANCO, we have decided that the analytes having the SSE values between 90% and 110% were 373 
considered as not to be affected by matrix effects. The distribution of SSE in all validated 374 
matrices is displayed in Figure 2. In general, the lowest matrix effects were observed for apple 375 
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puree. In this matrix, 59% and 43% of analytes were suppressed/enhanced by only <10% at HL 376 
and LL. For instance, signal intensity of patulin, the most common natural toxin found in apples 377 
and products thereof, was not affected by matrix in apple puree (Table 1) while it was highly 378 
suppressed (SSE of 42%) in pepper (Table 4). Concerning hazelnuts only 48% and 35% of 379 
analytes had the SSE in the range of 90-110% at HL and LL, respectively. 3-nitropropionic acid 380 
and sterigmatocystin found as the analytes with the highest incidence in hazelnuts in our recent 381 
study [31] were not affected by matrix effects at all. Aflatoxins which levels are regulated in nuts 382 
by the European Commission (EC) [4] were slightly suppressed in hazelnuts (SSE in the range of 383 
72-89%). However, the RE values for aflatoxins in hazelnuts close to 100% (Table 2) and the 384 
repeatability below 10% still allow to achieve accurate results in routine analysis. In total, only 385 
44% of analytes at the HL and 35% of analytes at the LL were not affected by matrix effects in 386 
maize. The mycotoxins with the legislation limits established in maize or cereals by the EC [4], 387 
such as deoxynivalenol, zearalenone and fumonisins B1 and B2, and ochratoxin A were neither 388 
suppressed nor enhanced at the HL (Table 3). As mentioned above, green pepper analysis 389 
suffered from the matrix effects the most from all investigated matrices which is obvious from a 390 
histogram in Figure 2. Only 10% of the analytes were not affected by signal 391 
suppression/enhancement in green pepper. From the compound on the reduced analyte list (Table 392 
4), only moniliformin was not affected by the matrix effects in green pepper. Some analytes, e.g. 393 
paspalic acid and aspyrone, could not be evaluated at all because of huge interferences occurred 394 
at the MRM transitions.  395 
Although mostly matrix-caused signal suppression is being observed in LC-MS [32], here both 396 
signal suppression and enhancement occurred in an equal extent in apple puree and hazelnuts 397 
independent of the spiking concentration. Interestingly, the same is not true for maize and green 398 
pepper. A higher number of analytes was suppressed (34% at HL, 42% at LL) than enhanced in 399 
maize (22% HL, 23% LL). Furthermore, the signal suppression was even more pronounced in 400 
pepper (Tables 4), in which 73% of analytes were suppressed as e.g. HT-2 toxin, T-2 toxin, 401 
alternariol, chanoclavine compared to 17% (HL) and 19% (LL) of analytes which were enhanced 402 
(e.g. zearalenone, 15-acetyldeoxynivalenol, decarestrictin, giberrellic acid). High enhancement 403 
calculated for some compounds such as cyclopiazonic acid, equisetin, CJ 20158 404 
(methylequisetin) and nortryptoquialanine for some or all matrices are probably not caused by 405 
matrix effects in the narrower sense i.e. in connection with the electrospray ionization process. In 406 
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these analyte/matrix combinations co-extracts are likely to work as a protective agent for light- 407 
or oxygen-sensitive analytes in the matrix-matched standards. The concentration of these 408 
analytes in neat solvent standards decreased much faster. For instance, a protective function of 409 
ascorbic acid (occurring in many plant matrices) against oxidation of cyclopiazonic acid has 410 
already been proven [33]. In addition to that, the matrix might also influence the epimerization 411 
rate e.g. of ergot alkaloids.  412 
Besides the SSE evaluation based on one point calibration, also their evaluation by comparing 413 
the slopes (matrix-matched standards slope/neat solvent standards slope) was performed. This 414 
approach is commonly used for the expression of matrix effects in validation studies. However, 415 
we observed that the ”slope SSE” do not reflect the real SSE for some analytes despite the 416 
linearity of calibration curves. For instance, the ”slope SSE” for tryptophol in hazelnut (97%) 417 
and maize (97%) did not indicate a matrix effect, but the ”one point SSE” calculated at the LL 418 
revealed a high signal suppression (139% and 195% for maize and pepper, respectively). 419 
Therefore, both approaches should be used for the expression of matrix effects within the 420 
validation process. When the ”slope SSE” and the ”one point calibration SSE” differ, the results 421 
should be corrected rather on the ”one point calibration SSE” calculated at the closest 422 
concentration level to the level found in a sample to avoid an erroneous quantification.  423 
Another difficulty is to estimate the extent of SSE, and also other performance characteristics, 424 
for analytes showing epimerization, like ergots alkaloids. A C9=C10 double bond of the ergoline 425 
ring is responsible for epimerization with respect to the centre of chirality C8 (Figure 3). Thus, 426 
ergot alkaloids are converted from –ine to –inine form and back depending on the solvent and 427 
pH. The –ine/–inine ratio can be different in the neat solvent and the matrix-matched 428 
environment [34]. For instance, epimers ergotamine and ergotaminine eluted at 7.51 and 7.67 429 
min showed the ratio shifted more to the latter one (Appendix B). However, as the ratio between 430 
these two epimers in the extract is not known, the calculated SSE, RA and RE cannot be 431 
considered as relevant for evaluation of routine samples. Instead, the data for dihydroergometrine 432 
which is eluted between ergotamine and ergotaminine (RT=7.62 min) could be considered. 433 
Dihydroergotamin is hydrogenated at positions C9 and C10, hence it does not exhibit 434 
epimerization.  435 
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3.2.1.3 Limits of detection and quantification, linearity 436 
The limits of quantification for all analytes were estimated as the lowest spiking level (LL) 437 
detectable at both MRM transitions at all five repetitions (Appendix B). As both parameters, the 438 
LOD and the LOQ, are strongly dependent on the actual condition of the instrument, i.e. the 439 
contamination level of the instrument, the lowest level approach is more feasible than the 440 
traditional S/N one, especially for the multi-analyte methods including more than one hundred 441 
analytes. In order to compare both approaches to LOQ determination, the calculation of LOD 442 
and LOQ according to signal to noise ratio (S/N) (Equations 4 and 5) was carried out as well, but 443 
only for 29 analytes listed in Tables 1-4. From Table 1-4 it is obvious that there is not a huge 444 
difference between LOQ (estimated from S/N ratio) and LL. Moreover, the levels of LOQ and 445 
LL are strongly dependent on the analyte/matrix combination. The highest difference between 446 
LOQ and LL was observed for citrinin in apple puree and for patulin in all matrices. Concerning 447 
the matrix influence on the detection capability of the method, the highest levels of LOQ and/or 448 
LL were obtained for green pepper. 449 
The linearity of the system for most of the analytes covered two orders of magnitude for all four 450 
matrices. For analytes for which a stock solution at the high concentration was available and 451 
which showed a high sensitivity, e.g.diacetoxyscirpenol and sterigmatocystin, the linear range of 452 
three orders of magnitude for all four matrices was obtained. 453 
3.2.2 Method precision  454 
The precision of the method was proven within the laboratory as repeatability of 5 repetitions at 455 
the highest and the lowest spiking level. Most of the analytes fulfilled the criteria of RSD ≤20%. 456 
An RSD of ≤20% was achieved for 97% of analytes in apple puree and hazelnuts and for 95% of 457 
compounds in maize. The repeatability below 20% of RSD for green pepper was obtained only 458 
for 89% of all analytes.  459 
As expected, the method precision at the LL was slightly worse compared to the HL. On 460 
average, 85% of the analytes passed the acceptable repeatability in all matrices except for pepper 461 
in which only 77% of the compounds fulfilled the recommended RSD at the LL. Ergot alkaloids 462 
belong to the analytes with higher repeatabilities (but still below 20%) which is caused by the 463 
epimerization between –ine and –inine form [34]. In general, the highest variation among the 464 
five repetitions was observed in green pepper. For instance, for aflatrem the RSD of 94% at the 465 
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HL was achieved. However, for some analytes the required repeatability was achieved in green 466 
pepper but not in any other matrix. Fumiquinazoline A in apple puree with an RSD of 104% and 467 
altenusin and geodin in maize with repeatabilities of 69% and 25% are example for this 468 
phenomenon (Appendix B).  469 
3.2.3 Method trueness 470 
The trueness of the method has been continuously proven by the participation in various 471 
proficiency tests provided by FAPAS
®
, Bipea and CODA-CERVA. The mycotoxin levels were 472 
obtained by means of neat solvent calibration curve and the results were corrected on the 473 
apparent recoveries of the respective toxins. Table 5 summarises the results of the recently 474 
performed proficiency tests that our laboratory participated in. The samples cover a wide range 475 
of analyte/matrix combinations. Therefore, the method trueness could have been proven also for 476 
the matrix types which were not validated, such as animal and chicken feed, cassava, milk 477 
powder. An apparent recovery of 100% was assumed for all these matrices. The z-scores 478 
calculated according to FAPAS
®
, Bipea and CODA-CERVA proficiency testing protocols for 479 
the all of the analyte/matrix combinations lied within the acceptable range of -2 to 2 except 480 
aflatoxin G2 in baby food (z-score = 2.62) and fumonisin B1 in maize (z-score = 2.97). 481 
Furthermore, it has been proven that the method provides accurate results also for matrices with 482 
high sugar content such as raisins. High sugar content matrices were not included into the 483 
validation process as they were not amenable to the miniaturization of the sample pretreatment to 484 
0.5 g which is necessary for spiking experiments in order to keep the amount of standards to a 485 
minimum. 486 
4. Conclusions 487 
The extension, optimization and validation of the LC-MS/MS method for the simultaneous 488 
determination of 295 fungal and bacterial metabolites has successfully been performed. The 489 
validation has been carried out for four types of different food matrices – apple puree, hazelnuts, 490 
maize and green pepper. Furthermore, the method trueness has been proved by the participation 491 
in the official proficiency tests organized by FAPAS
®
, Bipea and CODA-CERVA. The major 492 
outcomes are summarized in the following paragraphs:  493 
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 Validation data have been obtained for 295 analytes. In addition, the MS/MS transitions 494 
are provided for another 36 metabolites, for which, however, no sound validation could 495 
be realized due to non-availability of analytical standards or due to instability of these 496 
compounds under the used analytical conditions. 497 
 As compounds comprising a wide range of chemical properties have been included in the 498 
method, the extraction and chromatographic conditions had to be compromised. For 499 
instance, the acidic conditions essential for the extraction and separation of acidic 500 
compounds such as fumonisins, and ochratoxin A are not favourable for basic 501 
compounds (e.g. ergot alkaloids, enniatins). Therefore, the apparent recovery levels 502 
varied to a large extent depending on the analyte/matrix combination. In general, green 503 
pepper was the most difficult matrix in terms of recovery and matrix effects for the most 504 
of the analytes.  505 
 Both signal suppression and enhancement were observed for all four matrices. Their 506 
extent was dependent on the analyte/matrix combination and the analyte concentration. 507 
The matrix contributing the least to SSE was apple puree, while the highest number of 508 
analytes suffering from severe SSE were found in green pepper a. 509 
 Despite some analytes were out of the range of 70-120% apparent recoveries, the 510 
repeatability (RSD calculated from 5 replicates) was below the acceptable level of 20% 511 
for most of them.  512 
 The LOQs or LLs of the method for the toxins regulated by EC [3] were below the 513 
required maximum levels for the respective toxins except of aflatoxins and ochratoxin A 514 
in baby food and aflatoxin M1 in milk. 515 
 z-scores<׀2׀ were achieved at all proficiency tests the laboratory participated with the 516 
exception of aflatoxin G2 in babyfood (z-score = 2.62) and fumonisin B1 in maize (z-517 
score = 2.97).  518 
 519 
In summary this work describes a fully in-house validated LC-MS/MS multi-analyte method 520 
covering almost 300 bacterial and fungal metabolites including all relevant mycotoxins in 521 
various food matrices. 522 
 523 
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Table 1 664 
Performance characteristics of the method for some important analytes in apple puree 665 
Analyte 
RT 
(min) 
LOD 
(µg/kg) 
LOQ 
(µg/kg) 
LL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
HL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
3-nitropropionic 
acid 
3 0.6 1.9 14.4 80 89 71 7.3 480 78 88 53 8.1 
Aflatoxin B1 8.7 0.6 1.9 1.3 80 103 82 8 44 71 107 76 7.3 
Aflatoxin B2 8.4 1.2 4 1.3 58 99 57 13.4 44 78 84 65 8.7 
Aflatoxin G1 8 2.3 7.6 1.3 58 70 41 18.6 44 70 69 48 7.4 
Aflatoxin G2 7.7 2.6 8.7 1.3 72 141 88 21.6 44 79 92 72 4.5 
Aflatoxin M1 7.2 0.6 2.1 3.4 63 113 71 10.2 114 74 103 76 3.4 
Alternariol 11 0.5 1.6 2.3 80 107 86 3.3 77 81 108 87 2.1 
Alternariol 
monomethylether 
12.8 0.1 0.2 2.3 88 100 88 9.7 77 81 104 84 1.7 
Beauvericin 14.4 0.02 0.1 0.1 74 105 78 2.8 4 74 107 79 7 
Chanoclavine 5.7 0.1 0.3 0.2 81 101 297 2.7 6 77 85 66 3.6 
Citrinin 11.8 59.3 197.6 6.9 13 126 14 5.6 231 7 125 9 8.5 
Deoxynivalenol 5.6 12.7 42.2 15.1 75 107 80 3.3 629 81 111 90 3.5 
Diacetoxyscirpenol 8.5 0.8 2.6 4.7 147 107 129 15.5 155 80 102 81 7 
Emodin 14.3 0.1 0.4 2.3 73 100 73 3.8 55 77 102 79 3.7 
Enniatin B 14 0.006 0.021 0.1 91 151 137 13.2 2 82 103 84 2.8 
Enniatin B1 14.3 n.e. n.e. 0.1 105 167 174 8.8 5 80 110 88 4.4 
Enniatin A 14.9 n.e. n.e. 0.1 113 422 475 8.3 0.3 92 142 131 8.8 
Enniatin A1 14.6 n.e. n.e. 0.1 93 378 351 3.3 1.8 87 122 106 5.4 
Ergocryptine 8.1 1.5 4.8 2.6 87 71 62 16.9 9 59 126 74 12.9 
Ergocryptinine 9.4 0.1 0.4 1.9 66 97 69 5 6 74 91 67 7.5 
Fumonisin B1 9.4 2.6 8.6 17 72 108 73 3.4 565 76 108 82 3.9 
Fumonisin B2 11.3 2.8 9.2 17.1 69 131 71 6 569 78 103 80 2.8 
Fumonisin B3 10.3 2.1 6.9 0.9 72 103 87 20.6 9 77 107 83 5.9 
HT-2 Toxin 9.7 8.8 29.2 1.6 65 126 81 11.4 155 82 103 84 6.5 
Moniliformin 3.2 4.9 16.2 9.2 106 135 143 17.8 306 97 141 137 8.2 
Mycophenolic acid 10.7 2.2 7.3 6.5 43 92 58 15 215 80 99 79 4.3 
Nivalenol 4.8 2.5 8.3 4.7 89 169 150 6.2 155 67 143 96 5.8 
Ochratoxin A 11.9 1.2 3.8 3.9 80 96 76 5.4 130 73 107 78 9.7 
Patulin 4.9 35.9 119.7 36.8 77 100 77 5.3 369 82 100 82 4.8 
Phomopsin A 7.2 n.e. n.e. 35.1 n.d. n.d. n.d. n.d. 117 75 96 72 11.8 
Phomopsin B* 7.0 n.e. n.e. 1:30 61 119 73 9.3 1:10 77 103 79 5.5 
Sterigmatocystin 12.3 0.2 0.8 2.3 71 111 79 7.7 23 76 104 79 3.4 
T-2 Toxin 10.7 1 3.3 4.6 96 93 90 9.4 154 79 102 80 2.9 
Zearalenone 11.9 0.3 1 15.5 81 146 118 8.6 155 98 104 101 5.9 
Note: RT-retention time; LOD-limit of detection; LOQ-limit of quantification; LL-lowest validation level; HL-666 
highest validation level; RE-recovery of extraction step; RA-apparent recovery; SSE-signal 667 
suppression/enhancement; n.e.-not evaluated; n.d.-not detected; * concentration of the standard not known 668 
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Table 1 669 
Performance characteristics of the method for some important analytes in apple puree 670 
Analyte 
RT 
(min) 
LOD 
(µg/kg) 
LOQ 
(µg/kg) 
LL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
HL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
3-nitropropionic 
acid 
3 0.6 1.9 14.4 80 89 71 7.3 480 78 88 53 8.1 
Aflatoxin B1 8.7 0.6 1.9 1.3 80 103 82 8 44 71 107 76 7.3 
Aflatoxin B2 8.4 1.2 4 1.3 58 99 57 13.4 44 78 84 65 8.7 
Aflatoxin G1 8 2.3 7.6 1.3 58 70 41 18.6 44 70 69 48 7.4 
Aflatoxin G2 7.7 2.6 8.7 1.3 72 141 88 21.6 44 79 92 72 4.5 
Aflatoxin M1 7.2 0.6 2.1 3.4 63 113 71 10.2 114 74 103 76 3.4 
Alternariol 11 0.5 1.6 2.3 80 107 86 3.3 77 81 108 87 2.1 
Alternariol 
monomethylether 
12.8 0.1 0.2 2.3 88 100 88 9.7 77 81 104 84 1.7 
Beauvericin 14.4 0.02 0.1 0.1 74 105 78 2.8 4 74 107 79 7 
Chanoclavine 5.7 0.1 0.3 0.2 81 101 297 2.7 6 77 85 66 3.6 
Citrinin 11.8 59.3 197.6 6.9 13 126 14 5.6 231 7 125 9 8.5 
Deoxynivalenol 5.6 12.7 42.2 15.1 75 107 80 3.3 629 81 111 90 3.5 
Diacetoxyscirpenol 8.5 0.8 2.6 4.7 147 107 129 15.5 155 80 102 81 7 
Emodin 14.3 0.1 0.4 2.3 73 100 73 3.8 55 77 102 79 3.7 
Enniatin B 14 0.006 0.021 0.1 91 151 137 13.2 2 82 103 84 2.8 
Enniatin B1 14.3 n.e. n.e. 0.1 105 167 174 8.8 5 80 110 88 4.4 
Enniatin A 14.9 n.e. n.e. 0.1 113 422 475 8.3 0.3 92 142 131 8.8 
Enniatin A1 14.6 n.e. n.e. 0.1 93 378 351 3.3 1.8 87 122 106 5.4 
Ergocryptine 8.1 1.5 4.8 2.6 87 71 62 16.9 9 59 126 74 12.9 
Ergocryptinine 9.4 0.1 0.4 1.9 66 97 69 5 6 74 91 67 7.5 
Fumonisin B1 9.4 2.6 8.6 17 72 108 73 3.4 565 76 108 82 3.9 
Fumonisin B2 11.3 2.8 9.2 17.1 69 131 71 6 569 78 103 80 2.8 
Fumonisin B3 10.3 2.1 6.9 0.9 72 103 87 20.6 9 77 107 83 5.9 
HT-2 Toxin 9.7 8.8 29.2 1.6 65 126 81 11.4 155 82 103 84 6.5 
Moniliformin 3.2 4.9 16.2 9.2 106 135 143 17.8 306 97 141 137 8.2 
Mycophenolic acid 10.7 2.2 7.3 6.5 43 92 58 15 215 80 99 79 4.3 
Nivalenol 4.8 2.5 8.3 4.7 89 169 150 6.2 155 67 143 96 5.8 
Ochratoxin A 11.9 1.2 3.8 3.9 80 96 76 5.4 130 73 107 78 9.7 
Patulin 4.9 35.9 119.7 36.8 77 100 77 5.3 369 82 100 82 4.8 
Phomopsin A 7.2 n.e. n.e. 35.1 n.d. n.d. n.d. n.d. 117 75 96 72 11.8 
Phomopsin B* 7.0 n.e. n.e. 1:30 61 119 73 9.3 1:10 77 103 79 5.5 
Sterigmatocystin 12.3 0.2 0.8 2.3 71 111 79 7.7 23 76 104 79 3.4 
T-2 Toxin 10.7 1 3.3 4.6 96 93 90 9.4 154 79 102 80 2.9 
Zearalenone 11.9 0.3 1 15.5 81 146 118 8.6 155 98 104 101 5.9 
Note: RT-retention time; LOD-limit of detection; LOQ-limit of quantification; LL-lowest validation level; HL-671 
highest validation level; RE-recovery of extraction step; RA-apparent recovery; SSE-signal 672 
suppression/enhancement; n.e.-not evaluated; n.d.-not detected; * concentration of the standard not known 673 
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Table 1 674 
Performance characteristics of the method for some important analytes in apple puree 675 
Analyte 
RT 
(min) 
LOD 
(µg/kg) 
LOQ 
(µg/kg) 
LL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
HL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
3-nitropropionic 
acid 
3 0.6 1.9 14.4 80 89 71 7.3 480 78 88 53 8.1 
Aflatoxin B1 8.7 0.6 1.9 1.3 80 103 82 8 44 71 107 76 7.3 
Aflatoxin B2 8.4 1.2 4 1.3 58 99 57 13.4 44 78 84 65 8.7 
Aflatoxin G1 8 2.3 7.6 1.3 58 70 41 18.6 44 70 69 48 7.4 
Aflatoxin G2 7.7 2.6 8.7 1.3 72 141 88 21.6 44 79 92 72 4.5 
Aflatoxin M1 7.2 0.6 2.1 3.4 63 113 71 10.2 114 74 103 76 3.4 
Alternariol 11 0.5 1.6 2.3 80 107 86 3.3 77 81 108 87 2.1 
Alternariol 
monomethylether 
12.8 0.1 0.2 2.3 88 100 88 9.7 77 81 104 84 1.7 
Beauvericin 14.4 0.02 0.1 0.1 74 105 78 2.8 4 74 107 79 7 
Chanoclavine 5.7 0.1 0.3 0.2 81 101 297 2.7 6 77 85 66 3.6 
Citrinin 11.8 59.3 197.6 6.9 13 126 14 5.6 231 7 125 9 8.5 
Deoxynivalenol 5.6 12.7 42.2 15.1 75 107 80 3.3 629 81 111 90 3.5 
Diacetoxyscirpenol 8.5 0.8 2.6 4.7 147 107 129 15.5 155 80 102 81 7 
Emodin 14.3 0.1 0.4 2.3 73 100 73 3.8 55 77 102 79 3.7 
Enniatin B 14 0.006 0.021 0.1 91 151 137 13.2 2 82 103 84 2.8 
Enniatin B1 14.3 n.e. n.e. 0.1 105 167 174 8.8 5 80 110 88 4.4 
Enniatin A 14.9 n.e. n.e. 0.1 113 422 475 8.3 0.3 92 142 131 8.8 
Enniatin A1 14.6 n.e. n.e. 0.1 93 378 351 3.3 1.8 87 122 106 5.4 
Ergocryptine 8.1 1.5 4.8 2.6 87 71 62 16.9 9 59 126 74 12.9 
Ergocryptinine 9.4 0.1 0.4 1.9 66 97 69 5 6 74 91 67 7.5 
Fumonisin B1 9.4 2.6 8.6 17 72 108 73 3.4 565 76 108 82 3.9 
Fumonisin B2 11.3 2.8 9.2 17.1 69 131 71 6 569 78 103 80 2.8 
Fumonisin B3 10.3 2.1 6.9 0.9 72 103 87 20.6 9 77 107 83 5.9 
HT-2 Toxin 9.7 8.8 29.2 1.6 65 126 81 11.4 155 82 103 84 6.5 
Moniliformin 3.2 4.9 16.2 9.2 106 135 143 17.8 306 97 141 137 8.2 
Mycophenolic acid 10.7 2.2 7.3 6.5 43 92 58 15 215 80 99 79 4.3 
Nivalenol 4.8 2.5 8.3 4.7 89 169 150 6.2 155 67 143 96 5.8 
Ochratoxin A 11.9 1.2 3.8 3.9 80 96 76 5.4 130 73 107 78 9.7 
Patulin 4.9 35.9 119.7 36.8 77 100 77 5.3 369 82 100 82 4.8 
Phomopsin A 7.2 n.e. n.e. 35.1 n.d. n.d. n.d. n.d. 117 75 96 72 11.8 
Phomopsin B* 7.0 n.e. n.e. 1:30 61 119 73 9.3 1:10 77 103 79 5.5 
Sterigmatocystin 12.3 0.2 0.8 2.3 71 111 79 7.7 23 76 104 79 3.4 
T-2 Toxin 10.7 1 3.3 4.6 96 93 90 9.4 154 79 102 80 2.9 
Zearalenone 11.9 0.3 1 15.5 81 146 118 8.6 155 98 104 101 5.9 
Note: RT-retention time; LOD-limit of detection; LOQ-limit of quantification; LL-lowest validation level; HL-676 
highest validation level; RE-recovery of extraction step; RA-apparent recovery; SSE-signal 677 
suppression/enhancement; n.e.-not evaluated; n.d.-not detected; * concentration of the standard not known 678 
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Table 4 679 
Performance characteristics of the method for some important analytes in green pepper 680 
Analyte 
RT 
(min) 
LOD 
(µg/kg) 
LOQ 
(µg/kg) 
LL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
HL 
(µg/kg) 
RE 
(%) 
SSE 
(%) 
RA 
(%) 
RSD 
(%) 
3-nitropropionic 
acid 3.0 2.0 6.8 14.4 60 87 52 5.6 480 76 80 63 10.4 
Aflatoxin B1 8.7 8.0 26.5 13.1 75 41 33 12.0 44 78 40 31 4.9 
Aflatoxin B2 8.4 4.3 14.3 1.3 120 49 59 16.5 44 79 40 31 8.8 
Aflatoxin G1 8.0 5.2 17.2 13.2 69 64 44 3.8 44 73 69 50 8.6 
Aflatoxin G2 7.7 13.6 45.5 4.4 n.d. n.d. n.d. n.d. 46 59 53 31 8.0 
Aflatoxin M1 7.2 4.1 13.6 3.4 56 60 33 10.8 114 81 54 43 4.3 
Alternariol 11.0 9.4 31.2 7.7 88 46 40 9.4 77 72 40 29 10.9 
Alternariol 
monomethylether 12.8 0.5 1.7 23.3 97 105 102 13.4 77 96 94 90 11.3 
Beauvericin 14.4 0.02 0.06 0.1 110 151 167 7.3 4 83 56 46 6.5 
Chanoclavine 5.7 1.4 4.8 6.1 50 21 11 22.8 6 50 31 11 22.8 
Citrinin 11.8 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Deoxynivalenol 5.6 8.6 28.6 15.1 59 86 50 5.2 629 71 66 47 11.7 
Diacetoxyscirpenol 8.5 1.3 4.4 4.7 73 80 48 3.4 155 75 69 51 8.8 
Emodin 14.3 0.1 0.2 2.3 83 251 207 3.1 55 73 165 121 8.8 
Enniatin B 14.0 0.1 0.2 0.1 86 63 54 12.3 2 80 53 42 1.6 
Enniatin B1 14.3 n.e. n.e. 0.5 94 57 54 8.9 5 85 43 37 6.6 
Enniatin A 14.9 n.e. n.e. 0.1 74 61 38 9.2 0.3 74 51 38 9.2 
Enniatin A1 14.6 n.e. n.e. 0.2 81 68 55 6.9 2 82 60 50 5.2 
Ergocryptine 8.1 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ergocryptinine 9.4 3.6 11.9 6.2 n.d. n.d. n.d. n.d. 6 n.d. n.d. n.d. n.d. 
Fumonisin B1 9.4 5.7 18.8 17.0 74 125 93 10.5 565 71 88 63 6.8 
Fumonisin B2 11.3 5.7 18.9 17.1 71 104 62 6.4 567 76 87 67 6.7 
Fumonisin B3 10.3 2.4 7.9 0.9 71 166 118 15.4 9 95 88 84 7.8 
HT-2 Toxin 9.7 3.7 12.3 46.6 70 19 16 16.1 155 54 26 14 7.5 
Moniliformin 3.2 5.3 17.5 30.6 71 131 93 9.1 306 77 95 73 10.4 
Mycophenolic acid 10.7 8.7 28.9 21.5 77 79 60 10.9 215 79 72 57 3.3 
Nivalenol 4.8 8.1 27.0 15.5 63 88 48 5.1 155 63 65 41 6.1 
Ochratoxin A 11.9 3.9 12.9 3.9 67 69 47 9.7 130 68 55 37 0.5 
Patulin 4.9 134.6 448.6 110.6 n.d. n.d. n.d. n.d. 449 50 42 84 4.0 
Phomopsin A 7.2 n.e. n.e. n.d. n.d. n.d. n.d. n.d. 117.1 83 85 70 19.9 
Phomopsin B* 7.0 n.e. n.e. 1:10 98 71 70 14.6 1:30 69 86 59 6.9 
Sterigmatocystin 12.3 3.2 10.6 23.4 78 54 42 5.7 23 75 54 40 2.0 
T-2 Toxin 10.7 18.5 61.6 46.9 82 57 48 10.0 154 86 50 43 10.2 
Zearalenone 11.9 1.2 4.1 15.5 158 134 212 10.4 155 94 136 127 7.6 
Note: RT-retention time; LOD-limit of detection; LOQ-limit of quantification; LL-lowest validation level; HL-681 
highest validation level; RE-recovery of extraction step; RA-apparent recovery; SSE-signal 682 
suppression/enhancement; n.e.-not evaluated; n.d.-not detected; * concentration of the standard not known 683 
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Table 5 684 
Summary of the performed proficiency tests 685 
Organizator Matrix PT code Analyte 
Reported result 
(µg/kg) 
Assigned value 
(µg/kg) 
Standard 
deviation 
(µg/kg) 
Z-score 
FAPAS peanut T01044 Aflatoxin B1 3.37 3.94 1.74 -0.33 
   
Aflatoxin B2 1.62 1.54 0.68 0.12 
 
    Aflatoxin G1 2.53 2.27 1.00 0.26 
 
cereals T1786 Ochratoxin A 3.01 2.76 1.22 0.20 
 
maize T2246 Fumonisin B1 1665 1650 110 0.14 
 
    Fumonisin B2 474 461 32 0.41 
 
maize T2262 Deoxynivalenol 1707 1714 506 -0.01 
  
breakfast  
cereals 
T2257 Zearalenone 101.6 69.5 30.6 1.05 
BIPEA peanut cake 
 
Aflatoxin B1 452 481 277 -0.10 
   
Aflatoxin B2 88.2 77.1 51.1 0.22 
   
Aflatoxin G1 58.0 77.1 53.5 -0.36 
 
  
 
Aflatoxin G2 9.0 7.0 5.1 0.39 
 
peanut paste 
 
Aflatoxin B1 4.9 4.5 1.9 0.21 
 
  
 
Aflatoxin B2 1.29 0.9 0.3 1.30 
 
animal feed 
 
Ochratoxin A 1.29 1.6 1.0 -0.31 
   
HT-2 Toxin 17.2 15.0 3.0 0.73 
   
Deoxynivalenol 260 316 98 -0.57 
 
    Zearalenone 30.5 31.0 13.0 -0.04 
 
wheat 05-50631 Deoxynivalenol 1844 2223 485 -0.78 
 
    Zearalenone 36.2 20.0 8.0 2.03 
 
peanut paste 
 
Aflatoxin B1 4.2 7.2 3.7 -0.81 
   
Aflatoxin B2 0.2 0.7 0.4 -1.25 
   
Aflatoxin G1 0.7 2.6 1.5 -1.27 
 
    Aflatoxin G2 n.d. 0.4 0.2 n.e.  
 
wheat draff 02-2831 Ochratoxin A 7.2 5.7 2.6 0.58 
   
Deoxynivalenol 99 188 96 -0.93 
   
T-2 Toxin 95 84 31 0.35 
 
    HT-2 Toxin 105 82 25 0.92 
 
pepper 01-1031 Aflatoxin B1 1.2 2.0 0.8 -1.00 
 
animal feed 03-3031 Deoxynivalenol 258 291 82 -0.40 
 
raisins 02-3131 Ochratoxin A 2.9 3.7 1.6 -0.53 
 
maize 04-0731 Deoxynivalenol 702 563 119 1.17 
   
Zearalenone 45 53 14 -0.57 
   
Fumonisin B1 706 620 289 0.30 
 
    Fumonisin B2 187 149 68 0.56 
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milk powder 04-0331 Aflatoxin M1 0.309 0.395 0.173 -0.34 
 
maize   Deoxynivalenol 3400 3664 1176 -0.22 
   
Zearalenone 3478 2891 1836 0.32 
 
    Fumonisin B1 281 231 120 0.42 
 
coffee 02-1731 Ochratoxin A 8.5 8.7 4.2 -0.04 
 
wheat   Deoxynivalenol 946 852 230 0.41 
   
Nivalenol 29.9 n.e. n.e. n.e. 
 
    Ochratoxin A 2.4 2.8 0.7 -0.57 
 
baby food 01-3331 Aflatoxin B1 2.3 2.3 0.7 0.00 
   
Aflatoxin B2 1.1 1.1 0.2 0.00 
   
Aflatoxin G1 2.3 3.5 1.2 -1.01 
   
Aflatoxin G2 3.3 1.7 0.6 2.62 
   
Aflatoxin total 6.4 8.2 3.0 -0.60 
 
    Ochratoxin A 0.85 1.5 0.7 -0.93 
 
baby food 01-3431 Ochratoxin A 0.85 1.1 0.4 -0.63 
 
    HT-2 Toxin 49 55 30 -0.20 
 
type corn   T-2 Toxin 54.6 66.0 26.0 -0.44 
 
flour   Deoxynivalenol 129 127 55 0.04 
 
    Zearalenone 27.4 32.0 10.0 -0.46 
 
pepper 01-3231 Aflatoxin B1 6.5 12.0 5.9 -0.93 
   
Aflatoxin B2 8.7 10.3 4.4 -0.36 
   
Aflatoxin G1 6.7 7.7 3.2 -0.31 
   
Aflatoxin G2 5.5 5.3 3.2 0.06 
   
Aflatoxin total 27.3 31.6 15.2 -0.28 
 
    Ochratoxin A 8.9 5.5 3.3 1.03 
 
maize 05-0731 Fumonisin B1 1200 582 208 2.97 
   
Fumonisin B2 206 133 52 1.40 
   
Fumonisin B 
total 
1406 708 256 2.73 
   
Deoxynivalenol 939 730 178 1.17 
   
Zearalenone 142 124 32 0.56 
   
Ochratoxin A 7.0 5.0 1.9 1.05 
   
Nivalenol 443 453 159 -0.06 
   
T-2 Toxin 111 100 28 0.38 
   
HT-2 Toxin 92 82 20 0.51 
 
    sum T-2/HT-2 203 180 47 0.48 
 
pistachio  03-1431 Aflatoxin B1 17.3 18.3 3.7 -0.27 
 
paste 
 
Aflatoxin B2 10.8 11.7 2.5 -0.36 
   
Aflatoxin G1 8.9 9.6 2.7 -0.26 
   
Aflatoxin G2 3.0 4.3 1.1 -1.18 
   
Aflatoxin total 40.0 44.3 9.3 -0.46 
 
    Ochratoxin A 2.3 1.9 1.0 0.35 
  
 
30 
 
Chicken 04-3031 Ochratoxin A 10.2 9.0 2.7 0.44 
 
feed 
 
Deoxynivalenol 200 243 80 -0.54 
   
Nivalenol 14.4 n.e. n.e. n.e. 
   
T-2 Toxin 68 58 25 0.40 
   
HT-2 Toxin 62 51 15 0.73 
   
sum T-2/HT-2 130 111 46 0.41 
 
    Zearalenone 185 145 45 0.89 
 
liquorice 01-3531 Aflatoxin B1 8 21 18 -0.72 
   
Aflatoxin B2 0.75 3.4 2.8 -0.95 
   
Aflatoxin G1 5.3 15.3 12.7 -0.79 
   
Aflatoxin G2 3.5 8.2 6.3 -0.74 
   
Aflatoxin total 17.6 50.1 39.3 -0.83 
 
    Ochratoxin A 378.0 235.6 168.4 0.85 
 
oat 02-2931 Ochratoxin A 2.8 2.8 1 0.00 
   
Deoxynivalenol 84 128 45 -0.97 
   
Nivalenol 180 179 75 0.01 
   
T-2 Toxin 37 52 25 -0.60 
   
HT-2 Toxin 120 98 39 0.56 
   
sum T-2/HT-2 157 146 43 0.26 
      Zearalenone 70 79 29 -0.31 
CODA-
CERVA 
oat flour 
 
Aflatoxin B1 11.20 12.57 2.77 -0.49 
   
Aflatoxin B2 0.53 0.9 0.2 -1.85 
   
Aflatoxin G1 5.7 6.0 1.32 -0.25 
   
Aflatoxin G2 < 0.5 0.48 n.e. n.e. 
   
Ochratoxin A 108 79 17 1.67 
   
Deoxynivalenol 1635 2262 320 -1.96 
   
Zearalenone 210 191 39 0.48 
   
HT-2 Toxin 72.5 80.5 17.7 -0.45 
   
T-2 Toxin 308 270 53 0.72 
   
Fumonisin B1 2310 2313 326 -0.01 
   
Fumonisin B2 417 393 72 0.34 
   
Fumonisin B3 1280 1530 230 -1.09 
   
Enniatin A 2.6 2.3 0.5 0.54 
   
Enniatin A1 30.7 21.5 4.7 1.95 
   
Enniatin B 944 721 121 1.84 
   
Enniatin B1 258 194 40 1.63 
      Beauvericin 568 459 83 1.32 
Note: n.d.-not detected; n.e.-not evaluated 686 
 687 
 688 
